Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2013

Open Access 01-12-2013 | Review

Highlights of the 16th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance

Authors: John-Paul Carpenter, Amit R Patel, Juliano Lara Fernandes

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2013

Login to get access

Abstract

The 16th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR) took place in San Francisco, USA at the end of January 2013. With a faculty of experts from across the world, this congress provided a wealth of insight into cutting-edge research and technological development. This review article intends to provide a highlight of what represented the most significant advances in the field of cardiovascular magnetic resonance (CMR) during this year’s meeting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pennell DJ: Abstracts of the 16th annual SCMR scientific sessions. J Cardiovasc Magn Reson. 2013, 15 (Suppl 1): 1-481. Pennell DJ: Abstracts of the 16th annual SCMR scientific sessions. J Cardiovasc Magn Reson. 2013, 15 (Suppl 1): 1-481.
2.
go back to reference Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schonberg SO, Debl K, Strohm O, Ahlstrom H: Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial). J Cardiovasc Magn Reson. 2012, 14: 61-10.1186/1532-429X-14-61.PubMedCentralCrossRefPubMed Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schonberg SO, Debl K, Strohm O, Ahlstrom H: Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial). J Cardiovasc Magn Reson. 2012, 14: 61-10.1186/1532-429X-14-61.PubMedCentralCrossRefPubMed
3.
go back to reference Kellman P, Wilson JR, Xue H, Ugander M, Arai AE: Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012, 14: 63-10.1186/1532-429X-14-63.PubMedCentralCrossRefPubMed Kellman P, Wilson JR, Xue H, Ugander M, Arai AE: Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012, 14: 63-10.1186/1532-429X-14-63.PubMedCentralCrossRefPubMed
4.
go back to reference Mekkaoui C, Huang S, Chen HH, Dai G, Reese TG, Kostis WJ, Thiagalingam A, Maurovich-Horvat P, Ruskin JN, Hoffmann U: Fiber architecture in remodeled myocardium revealed with a quantitative diffusion CMR tractography framework and histological validation. J Cardiovasc Magn Reson. 2012, 14: 70-10.1186/1532-429X-14-70.PubMedCentralCrossRefPubMed Mekkaoui C, Huang S, Chen HH, Dai G, Reese TG, Kostis WJ, Thiagalingam A, Maurovich-Horvat P, Ruskin JN, Hoffmann U: Fiber architecture in remodeled myocardium revealed with a quantitative diffusion CMR tractography framework and histological validation. J Cardiovasc Magn Reson. 2012, 14: 70-10.1186/1532-429X-14-70.PubMedCentralCrossRefPubMed
5.
go back to reference Oshinski JN, Delfino JG, Sharma P, Gharib AM, Pettigrew RI: Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson. 2010, 12: 55-10.1186/1532-429X-12-55.PubMedCentralCrossRefPubMed Oshinski JN, Delfino JG, Sharma P, Gharib AM, Pettigrew RI: Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson. 2010, 12: 55-10.1186/1532-429X-12-55.PubMedCentralCrossRefPubMed
6.
go back to reference Snyder CJ, DelaBarre L, Metzger GJ, van de Moortele PF, Akgun C, Ugurbil K, Vaughan JT: Initial results of cardiac imaging at 7 Tesla. Magn Reson Med. 2009, 61: 517-24. 10.1002/mrm.21895.PubMedCentralCrossRefPubMed Snyder CJ, DelaBarre L, Metzger GJ, van de Moortele PF, Akgun C, Ugurbil K, Vaughan JT: Initial results of cardiac imaging at 7 Tesla. Magn Reson Med. 2009, 61: 517-24. 10.1002/mrm.21895.PubMedCentralCrossRefPubMed
7.
go back to reference Nielles-Vallespin S, Mekkaoui C, Gatehouse P, Reese TG, Keegan J, Ferreira PF, Collins S, Speier P, Feiweier T, de Silva R: In vivo diffusion tensor MRI of the human heart: reproducibility of breath-hold and navigator-based approaches. Magn Reson Med. 2012, 12: 17- Nielles-Vallespin S, Mekkaoui C, Gatehouse P, Reese TG, Keegan J, Ferreira PF, Collins S, Speier P, Feiweier T, de Silva R: In vivo diffusion tensor MRI of the human heart: reproducibility of breath-hold and navigator-based approaches. Magn Reson Med. 2012, 12: 17-
8.
go back to reference McGill LA, Ismail TF, Nielles-Vallespin S, Ferreira P, Scott AD, Roughton M, Kilner PJ, Ho SY, McCarthy KP, Gatehouse PD: Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012, 14: 86-10.1186/1532-429X-14-86.PubMedCentralCrossRefPubMed McGill LA, Ismail TF, Nielles-Vallespin S, Ferreira P, Scott AD, Roughton M, Kilner PJ, Ho SY, McCarthy KP, Gatehouse PD: Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012, 14: 86-10.1186/1532-429X-14-86.PubMedCentralCrossRefPubMed
9.
go back to reference Ferreira PJ, Nielles-Vallespin S, Gatehouse PD, de Silva R, Keegan J, Speier P, Feiweier T, Reese TG, Ismail TF, Scott A: Cardiac diffusion tensor imaging: helix angle (HA) healthy statistical average technique for HA quantification in vivo. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W7-PubMedCentralCrossRef Ferreira PJ, Nielles-Vallespin S, Gatehouse PD, de Silva R, Keegan J, Speier P, Feiweier T, Reese TG, Ismail TF, Scott A: Cardiac diffusion tensor imaging: helix angle (HA) healthy statistical average technique for HA quantification in vivo. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W7-PubMedCentralCrossRef
10.
go back to reference Teh I, Lohezic M, Aksentijevic D, Schneider JE: Accelerated fast spin echo diffusion spectrum imaging in the mouse heart ex-vivo. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W6-10.1186/1532-429X-15-S1-W6.PubMedCentralCrossRef Teh I, Lohezic M, Aksentijevic D, Schneider JE: Accelerated fast spin echo diffusion spectrum imaging in the mouse heart ex-vivo. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W6-10.1186/1532-429X-15-S1-W6.PubMedCentralCrossRef
11.
go back to reference Krug JW, Rose G, Stucht D, Clifford G, Oster J: Limitations of VCG based gating methods in ultra high field cardiac MRI. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W19-10.1186/1532-429X-15-S1-W19.PubMedCentralCrossRef Krug JW, Rose G, Stucht D, Clifford G, Oster J: Limitations of VCG based gating methods in ultra high field cardiac MRI. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W19-10.1186/1532-429X-15-S1-W19.PubMedCentralCrossRef
12.
go back to reference Tse Z, Dumoulin C, Watkins R, Butts Pauly K, Kwong RY, Michaud GF, Stevenson W, Joslesz F, Schmidt EJ: Improved cardiac gating at 3T with the “3D-QRS” method utilizing MRIcompatible 12-lead ECGs. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W20-10.1186/1532-429X-15-S1-E20.PubMedCentralCrossRef Tse Z, Dumoulin C, Watkins R, Butts Pauly K, Kwong RY, Michaud GF, Stevenson W, Joslesz F, Schmidt EJ: Improved cardiac gating at 3T with the “3D-QRS” method utilizing MRIcompatible 12-lead ECGs. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): W20-10.1186/1532-429X-15-S1-E20.PubMedCentralCrossRef
13.
go back to reference Kahlert P, Parohl N, Albert J, Schafer L, Reinhardt R, Kaiser GM, McDougall I, Decker B, Plicht B, Erbel R: Real-time magnetic resonance imaging-guided transarterial aortic valve implantation: in vivo evaluation in swine. J Am Coll Cardiol. 2012, 59: 192-3. 10.1016/j.jacc.2011.09.046.CrossRefPubMed Kahlert P, Parohl N, Albert J, Schafer L, Reinhardt R, Kaiser GM, McDougall I, Decker B, Plicht B, Erbel R: Real-time magnetic resonance imaging-guided transarterial aortic valve implantation: in vivo evaluation in swine. J Am Coll Cardiol. 2012, 59: 192-3. 10.1016/j.jacc.2011.09.046.CrossRefPubMed
14.
go back to reference Aneja A, Ono C, Scandling D, Jin N, Hinton AM, Pennell M, Raman SV, Simonetti OP: Left ventricular function, aortic velocity, and late gadolinium enhancement assessed by real-time and single shot CMR is comparable to breath-held segmented imaging: a prospective study. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O51-10.1186/1532-429X-15-S1-O51.PubMedCentralCrossRef Aneja A, Ono C, Scandling D, Jin N, Hinton AM, Pennell M, Raman SV, Simonetti OP: Left ventricular function, aortic velocity, and late gadolinium enhancement assessed by real-time and single shot CMR is comparable to breath-held segmented imaging: a prospective study. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O51-10.1186/1532-429X-15-S1-O51.PubMedCentralCrossRef
15.
go back to reference Gamper U, Boesiger P, Kozerke S: Compressed sensing in dynamic MRI. Magn Reson Med. 2008, 59: 365-73. 10.1002/mrm.21477.CrossRefPubMed Gamper U, Boesiger P, Kozerke S: Compressed sensing in dynamic MRI. Magn Reson Med. 2008, 59: 365-73. 10.1002/mrm.21477.CrossRefPubMed
16.
go back to reference Schmidt M, Ekinci O, Liu J, Lefebvre A, Nadar MS, Mueller E, Zenge MO: Novel highly accelerated real-time CINE-MRI featuring compressed sensing with k-t regularization in comparison to TSENSE segmented and real-time Cine imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P36-10.1186/1532-429X-15-S1-P36.PubMedCentralCrossRef Schmidt M, Ekinci O, Liu J, Lefebvre A, Nadar MS, Mueller E, Zenge MO: Novel highly accelerated real-time CINE-MRI featuring compressed sensing with k-t regularization in comparison to TSENSE segmented and real-time Cine imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P36-10.1186/1532-429X-15-S1-P36.PubMedCentralCrossRef
17.
go back to reference Jogiya R, Kozerke S, Morton G, De Silva K, Redwood S, Perera D, Nagel E, Plein S: Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. J Am Coll Cardiol. 2012, 60: 756-65. 10.1016/j.jacc.2012.02.075.CrossRefPubMed Jogiya R, Kozerke S, Morton G, De Silva K, Redwood S, Perera D, Nagel E, Plein S: Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. J Am Coll Cardiol. 2012, 60: 756-65. 10.1016/j.jacc.2012.02.075.CrossRefPubMed
18.
go back to reference Chen X, Salerno M, Epstein FH: Accelerated first-pass perfusion CMR using compressed sensing with regional spatiotemporal sparsity. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): E16-PubMedCentral Chen X, Salerno M, Epstein FH: Accelerated first-pass perfusion CMR using compressed sensing with regional spatiotemporal sparsity. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): E16-PubMedCentral
19.
go back to reference Tsao J: Ultrafast imaging: principles, pitfalls, solutions, and applications. J Magn Reson Imaging. 2010, 32: 252-66. 10.1002/jmri.22239.CrossRefPubMed Tsao J: Ultrafast imaging: principles, pitfalls, solutions, and applications. J Magn Reson Imaging. 2010, 32: 252-66. 10.1002/jmri.22239.CrossRefPubMed
20.
go back to reference Sharif B, Dharmakumar R, Arsanjani R, Thomson LE, Merz NB, Berman DS, Li D: Ungated cine first-pass CMR for concurrent imaging of myocardial perfusion defects and wall motion abnormalities. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O1-10.1186/1532-429X-15-S1-O1.PubMedCentralCrossRef Sharif B, Dharmakumar R, Arsanjani R, Thomson LE, Merz NB, Berman DS, Li D: Ungated cine first-pass CMR for concurrent imaging of myocardial perfusion defects and wall motion abnormalities. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O1-10.1186/1532-429X-15-S1-O1.PubMedCentralCrossRef
21.
go back to reference Yang Y, Feng X, Meyer CH, Kramer CM, Salerno M: First-pass myocardial perfusion imaging with whole ventricular coverage using L1-SPIRIT accelerated spiral trajectories. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P20-10.1186/1532-429X-15-S1-E20.PubMedCentralCrossRef Yang Y, Feng X, Meyer CH, Kramer CM, Salerno M: First-pass myocardial perfusion imaging with whole ventricular coverage using L1-SPIRIT accelerated spiral trajectories. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P20-10.1186/1532-429X-15-S1-E20.PubMedCentralCrossRef
22.
go back to reference Petersson S, Sigfridsson A, Carlhall CJ, Ebbers T: Retrospectively gated intra-cardiac 4D flow CMR using spiral k-space trajectories. J Cardiovasc Magn Reson. 2013, 15 (supll 1): O64-PubMedCentral Petersson S, Sigfridsson A, Carlhall CJ, Ebbers T: Retrospectively gated intra-cardiac 4D flow CMR using spiral k-space trajectories. J Cardiovasc Magn Reson. 2013, 15 (supll 1): O64-PubMedCentral
23.
go back to reference Biglands JD, Radjenovic A, Ridgway JP: Cardiovascular magnetic resonance physics for clinicians: part II. J Cardiovasc Magn Reson. 2012, 14: 66-10.1186/1532-429X-14-66.PubMedCentralCrossRefPubMed Biglands JD, Radjenovic A, Ridgway JP: Cardiovascular magnetic resonance physics for clinicians: part II. J Cardiovasc Magn Reson. 2012, 14: 66-10.1186/1532-429X-14-66.PubMedCentralCrossRefPubMed
24.
go back to reference Sharif B, Dharmakumar R, LaBounty T, Shufelt C, Thomson LE, Merz NB, Berman DS, Li D: Eliminating dark-rim artifacts in first-pass myocardial perfusion imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O3-PubMedCentralCrossRef Sharif B, Dharmakumar R, LaBounty T, Shufelt C, Thomson LE, Merz NB, Berman DS, Li D: Eliminating dark-rim artifacts in first-pass myocardial perfusion imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O3-PubMedCentralCrossRef
25.
go back to reference Wu Y, Yang F, Chung Y-C: Robust and fast SSFP for the evaluation of LV function at 3T. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O52-10.1186/1532-429X-15-S1-E52.PubMedCentralCrossRef Wu Y, Yang F, Chung Y-C: Robust and fast SSFP for the evaluation of LV function at 3T. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O52-10.1186/1532-429X-15-S1-E52.PubMedCentralCrossRef
26.
go back to reference Rothstein T, Camargo GC, Quintella DC, Fernandes E, Strecker R, Greiser A, Derenne ME, Lima M, Moojen JJ, Rizzi PB: Artifact suppression of SSFP cine sequences at 3T using a novel automatic 3D shimming algorithm. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P57-10.1186/1532-429X-15-S1-E57.PubMedCentralCrossRef Rothstein T, Camargo GC, Quintella DC, Fernandes E, Strecker R, Greiser A, Derenne ME, Lima M, Moojen JJ, Rizzi PB: Artifact suppression of SSFP cine sequences at 3T using a novel automatic 3D shimming algorithm. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P57-10.1186/1532-429X-15-S1-E57.PubMedCentralCrossRef
27.
go back to reference White SK, Sado DM, Flett AS, Moon JC: Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart. 2012, 98: 773-9. 10.1136/heartjnl-2011-301515.CrossRefPubMed White SK, Sado DM, Flett AS, Moon JC: Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart. 2012, 98: 773-9. 10.1136/heartjnl-2011-301515.CrossRefPubMed
28.
go back to reference Fitts M, Breton E, Kholmovski E, Dosdall DJ, Vijayakumar S, Hong KP, Ranjan R, Marrouche NF, Axel L, Kim D: Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O112-10.1186/1532-429X-15-S1-O112.PubMedCentralCrossRef Fitts M, Breton E, Kholmovski E, Dosdall DJ, Vijayakumar S, Hong KP, Ranjan R, Marrouche NF, Axel L, Kim D: Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O112-10.1186/1532-429X-15-S1-O112.PubMedCentralCrossRef
29.
go back to reference Slavin GS, Stainsby JA: True T1 mapping with SMART1Map (saturation method using adaptive recovery times for cardiac T1 mapping): a comparison with MOLLI. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P3-PubMedCentral Slavin GS, Stainsby JA: True T1 mapping with SMART1Map (saturation method using adaptive recovery times for cardiac T1 mapping): a comparison with MOLLI. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P3-PubMedCentral
30.
go back to reference Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD: Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 And 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010, 12: 69-10.1186/1532-429X-12-69.PubMedCentralCrossRefPubMed Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD: Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 And 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010, 12: 69-10.1186/1532-429X-12-69.PubMedCentralCrossRefPubMed
31.
go back to reference Henningsson M, Botnar RM, Voigt T: 3D saturation recovery imaging for free breathing myocardial T1 mapping. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P44-PubMedCentralCrossRef Henningsson M, Botnar RM, Voigt T: 3D saturation recovery imaging for free breathing myocardial T1 mapping. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): P44-PubMedCentralCrossRef
32.
go back to reference Biglino G, Verschueren P, Zegels R, Taylor AM, Schievano S: Rapid prototyping compliant arterial phantoms for in-vitro studies and device testing. J Cardiovasc Magn Reson. 2013, 15: 2-10.1186/1532-429X-15-2.PubMedCentralCrossRefPubMed Biglino G, Verschueren P, Zegels R, Taylor AM, Schievano S: Rapid prototyping compliant arterial phantoms for in-vitro studies and device testing. J Cardiovasc Magn Reson. 2013, 15: 2-10.1186/1532-429X-15-2.PubMedCentralCrossRefPubMed
33.
go back to reference Acevedo-Bolton G, Saloner D: Using MRI derived patient-specific flow models and flow imaging for flow diverting stent rehearsal. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O56-PubMedCentral Acevedo-Bolton G, Saloner D: Using MRI derived patient-specific flow models and flow imaging for flow diverting stent rehearsal. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O56-PubMedCentral
34.
go back to reference Jiji RS, Pollak AW, Epstein FH, Antkowiak PF, Meyer CH, Weltman AL, Lopez D, Dimaria JM, Hunter JR, Christopher JM, Kramer CM: Reproducibility of rest and exercise stress contrast-enhanced calf perfusion magnetic resonance imaging in peripheral arterial disease. J Cardiovasc Magn Reson. 2013, 15: 14-10.1186/1532-429X-15-14.PubMedCentralCrossRefPubMed Jiji RS, Pollak AW, Epstein FH, Antkowiak PF, Meyer CH, Weltman AL, Lopez D, Dimaria JM, Hunter JR, Christopher JM, Kramer CM: Reproducibility of rest and exercise stress contrast-enhanced calf perfusion magnetic resonance imaging in peripheral arterial disease. J Cardiovasc Magn Reson. 2013, 15: 14-10.1186/1532-429X-15-14.PubMedCentralCrossRefPubMed
35.
go back to reference Clement-Guinaudeau S, Topel ML, Ali A, Poole JC, Rocco E, Khan SA, Zhong X, Epstein FH, Kramer CM, Quyyumi AA, Oshinski JN: MR-based calf muscle perfusion index correlates with treadmill exercise test parameters in patients with peripheral arterial disease. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O58-10.1186/1532-429X-15-S1-P58.PubMedCentralCrossRef Clement-Guinaudeau S, Topel ML, Ali A, Poole JC, Rocco E, Khan SA, Zhong X, Epstein FH, Kramer CM, Quyyumi AA, Oshinski JN: MR-based calf muscle perfusion index correlates with treadmill exercise test parameters in patients with peripheral arterial disease. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O58-10.1186/1532-429X-15-S1-P58.PubMedCentralCrossRef
36.
go back to reference Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, Nothnagel D, Steen H, Petersen S, Nagel E: European cardiovascular magnetic resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013, 15: 9-10.1186/1532-429X-15-9.PubMedCentralCrossRefPubMed Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, Nothnagel D, Steen H, Petersen S, Nagel E: European cardiovascular magnetic resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013, 15: 9-10.1186/1532-429X-15-9.PubMedCentralCrossRefPubMed
37.
go back to reference Andre F, Celik C, Abdel-Aty H, Santos MFB, Giannitsis E, Katus H, Steen H: Comparison of parameters for left ventricular volumes and function between echocardiography and cardiovascular magnetic resonance in a large group of cardiac patients. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): E74-10.1186/1532-429X-15-S1-E74.PubMedCentralCrossRef Andre F, Celik C, Abdel-Aty H, Santos MFB, Giannitsis E, Katus H, Steen H: Comparison of parameters for left ventricular volumes and function between echocardiography and cardiovascular magnetic resonance in a large group of cardiac patients. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): E74-10.1186/1532-429X-15-S1-E74.PubMedCentralCrossRef
38.
go back to reference Joshi SB, Connelly KA, Jimenez-Juan L, Hansen M, Kirpalani A, Dorian P, Mangat I, Al-Hesayen A, Crean AM, Wright GA: Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson. 2012, 14: 69-10.1186/1532-429X-14-69.PubMedCentralCrossRefPubMed Joshi SB, Connelly KA, Jimenez-Juan L, Hansen M, Kirpalani A, Dorian P, Mangat I, Al-Hesayen A, Crean AM, Wright GA: Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson. 2012, 14: 69-10.1186/1532-429X-14-69.PubMedCentralCrossRefPubMed
39.
go back to reference Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JM, Kellman P, Cook SC, Schwartzman DS, Simon MA: Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson. 2013, 15: 6-10.1186/1532-429X-15-6.PubMedCentralCrossRefPubMed Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JM, Kellman P, Cook SC, Schwartzman DS, Simon MA: Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson. 2013, 15: 6-10.1186/1532-429X-15-6.PubMedCentralCrossRefPubMed
40.
go back to reference Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P: Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation. 2011, 124: 1351-60. 10.1161/CIRCULATIONAHA.110.011346.CrossRefPubMed Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P: Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation. 2011, 124: 1351-60. 10.1161/CIRCULATIONAHA.110.011346.CrossRefPubMed
41.
go back to reference Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ: Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012, 379: 453-60. 10.1016/S0140-6736(11)61335-4.PubMedCentralCrossRefPubMed Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ: Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012, 379: 453-60. 10.1016/S0140-6736(11)61335-4.PubMedCentralCrossRefPubMed
42.
go back to reference Greenwood JP, Walker S, Giardin F, McKenna C, Everett C, Nixon J, Brown J, Plein MS: Cost-effectiveness of magnetic resonance imaging in coronary heart disease: an economic evaluation using data from the CE-MARC study. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O7-10.1186/1532-429X-15-S1-O7.PubMedCentralCrossRef Greenwood JP, Walker S, Giardin F, McKenna C, Everett C, Nixon J, Brown J, Plein MS: Cost-effectiveness of magnetic resonance imaging in coronary heart disease: an economic evaluation using data from the CE-MARC study. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O7-10.1186/1532-429X-15-S1-O7.PubMedCentralCrossRef
43.
go back to reference Kelle S, Petrov G, Kern S, Fleck E, Wellnhofer E: Cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in stable coronary artery disease - a post-hoc analysis. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O8-10.1186/1532-429X-15-S1-W8.PubMedCentralCrossRef Kelle S, Petrov G, Kern S, Fleck E, Wellnhofer E: Cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in stable coronary artery disease - a post-hoc analysis. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O8-10.1186/1532-429X-15-S1-W8.PubMedCentralCrossRef
44.
go back to reference Genders TS, Petersen SE, Pugliese F, Dastidar AG, Fleischmann KE, Nieman K, Hunink M: Stress myocardial perfusion cardiac magnetic resonance imaging vs. coronary CT angiography in the diagnostic work-up of patients with stable chest pain: comparative effectiveness and costs. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O9-PubMedCentral Genders TS, Petersen SE, Pugliese F, Dastidar AG, Fleischmann KE, Nieman K, Hunink M: Stress myocardial perfusion cardiac magnetic resonance imaging vs. coronary CT angiography in the diagnostic work-up of patients with stable chest pain: comparative effectiveness and costs. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O9-PubMedCentral
45.
go back to reference Plein S, Herzog BA, Maredia N, Kidambi A, Motwani M, Uddin A, Ripley DP, Dickinson CJ, Brown J, Nixon J: The ischaemic and scar burden measured by cardiac magnetic resonance imaging in patients with ischaemic coronary heart disease from the CE-MARC study. J Cardiovasc Magn Reson. 2013, 15 (suppl1): O105-PubMedCentral Plein S, Herzog BA, Maredia N, Kidambi A, Motwani M, Uddin A, Ripley DP, Dickinson CJ, Brown J, Nixon J: The ischaemic and scar burden measured by cardiac magnetic resonance imaging in patients with ischaemic coronary heart disease from the CE-MARC study. J Cardiovasc Magn Reson. 2013, 15 (suppl1): O105-PubMedCentral
46.
go back to reference Manka R, Gebker R, Wissmann L, Jogiya R, Motwani M, Frick M, Reinartz SD, Schnackenburg B, Nagel E, Plein S, Kozerke S: Multicenter evaluation of dynamic three-dimensional whole-heart myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O103-PubMedCentral Manka R, Gebker R, Wissmann L, Jogiya R, Motwani M, Frick M, Reinartz SD, Schnackenburg B, Nagel E, Plein S, Kozerke S: Multicenter evaluation of dynamic three-dimensional whole-heart myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O103-PubMedCentral
47.
go back to reference Parsai C, O’Hanlon R, Prasad SK, Mohiaddin RH: Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012, 14: 54-10.1186/1532-429X-14-54.PubMedCentralCrossRefPubMed Parsai C, O’Hanlon R, Prasad SK, Mohiaddin RH: Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012, 14: 54-10.1186/1532-429X-14-54.PubMedCentralCrossRefPubMed
48.
go back to reference Maron MS: Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012, 14: 13-10.1186/1532-429X-14-13.PubMedCentralCrossRefPubMed Maron MS: Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012, 14: 13-10.1186/1532-429X-14-13.PubMedCentralCrossRefPubMed
49.
go back to reference Ismail TF, Jabbour A, Gulati A, Mallorie A, Raza S, Cowling TE, Das B, Khwaja J, Wage R, Moon J: Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O67-10.1186/1532-429X-15-S1-O67.PubMedCentralCrossRef Ismail TF, Jabbour A, Gulati A, Mallorie A, Raza S, Cowling TE, Das B, Khwaja J, Wage R, Moon J: Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O67-10.1186/1532-429X-15-S1-O67.PubMedCentralCrossRef
50.
go back to reference Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, Ho C, Bluemke DA: The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012, 14: 17-10.1186/1532-429X-14-17.PubMedCentralCrossRefPubMed Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, Ho C, Bluemke DA: The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012, 14: 17-10.1186/1532-429X-14-17.PubMedCentralCrossRefPubMed
51.
go back to reference Deva DP, Williams LK, Care M, Siminovitch KA, Moshonov H, Wintersperger BJ, Rakowski H, Crean AM: Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O33-10.1186/1532-429X-15-S1-O33.PubMedCentralCrossRef Deva DP, Williams LK, Care M, Siminovitch KA, Moshonov H, Wintersperger BJ, Rakowski H, Crean AM: Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O33-10.1186/1532-429X-15-S1-O33.PubMedCentralCrossRef
52.
go back to reference Flett A, Maestrini V, Milliken D, Fontana M, Harb R, Sado D, Quarta G, Herrey AS, Elliott P, McKenna WJ, Moon J: A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O36-10.1186/1532-429X-15-S1-O36.PubMedCentralCrossRef Flett A, Maestrini V, Milliken D, Fontana M, Harb R, Sado D, Quarta G, Herrey AS, Elliott P, McKenna WJ, Moon J: A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O36-10.1186/1532-429X-15-S1-O36.PubMedCentralCrossRef
53.
go back to reference Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD: Identification and assessment of anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial t1 mapping. Circ Cardiovasc Imaging. 2013, 6: 392-8. 10.1161/CIRCIMAGING.112.000070.CrossRefPubMed Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD: Identification and assessment of anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial t1 mapping. Circ Cardiovasc Imaging. 2013, 6: 392-8. 10.1161/CIRCIMAGING.112.000070.CrossRefPubMed
54.
go back to reference Simpson R, Keegan J, Firmin D: Efficient and reproducible high resolution spiral myocardial phase velocity mapping of the entire cardiac cycle. J Cardiovasc Magn Reson. 2013, 15: 34-10.1186/1532-429X-15-34.PubMedCentralCrossRefPubMed Simpson R, Keegan J, Firmin D: Efficient and reproducible high resolution spiral myocardial phase velocity mapping of the entire cardiac cycle. J Cardiovasc Magn Reson. 2013, 15: 34-10.1186/1532-429X-15-34.PubMedCentralCrossRefPubMed
55.
go back to reference Alexandre J, Saloux E, Dugue AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P, Milliez P: Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson. 2013, 15: 12-10.1186/1532-429X-15-12.PubMedCentralCrossRefPubMed Alexandre J, Saloux E, Dugue AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P, Milliez P: Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson. 2013, 15: 12-10.1186/1532-429X-15-12.PubMedCentralCrossRefPubMed
56.
go back to reference Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, Auricchio A: Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011, 13: 29-10.1186/1532-429X-13-29.PubMedCentralCrossRefPubMed Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, Auricchio A: Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011, 13: 29-10.1186/1532-429X-13-29.PubMedCentralCrossRefPubMed
57.
go back to reference Tse Z, Dumoulin C, Byrd I, Schweitzer J, Watkins R, Pauly KB, Kwong RY, Michaud GF, Stevenson W, Jolesz F, Schmidt EJ: Voltage-based electroanatomic mapping system for MR-guided cardiac electrophysiology: preliminary swine validations. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O88-10.1186/1532-429X-15-S1-O88.PubMedCentralCrossRef Tse Z, Dumoulin C, Byrd I, Schweitzer J, Watkins R, Pauly KB, Kwong RY, Michaud GF, Stevenson W, Jolesz F, Schmidt EJ: Voltage-based electroanatomic mapping system for MR-guided cardiac electrophysiology: preliminary swine validations. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O88-10.1186/1532-429X-15-S1-O88.PubMedCentralCrossRef
58.
go back to reference Ramanan V, Celik H, Ghate S, Barry J, Ghugre NR, Leber V, Stainsby JA, Shmatukha A, Shurrab M, Crystal E, Wright G: Exploring intrinsic MR signal relaxation in acute RF ablation lesions using T2 mapping and IR-SSFP CINE imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O87-10.1186/1532-429X-15-S1-O87.PubMedCentralCrossRef Ramanan V, Celik H, Ghate S, Barry J, Ghugre NR, Leber V, Stainsby JA, Shmatukha A, Shurrab M, Crystal E, Wright G: Exploring intrinsic MR signal relaxation in acute RF ablation lesions using T2 mapping and IR-SSFP CINE imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O87-10.1186/1532-429X-15-S1-O87.PubMedCentralCrossRef
59.
go back to reference Ainslie M, Miller CA, Brown B, Davidson N, Fox DJ, Schmitt M: Multiparametric CMR assessment of RV apical versus septal Pacing Study (MAPS) - preliminary acute hemodynamic findings. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O85-10.1186/1532-429X-15-S1-P85.PubMedCentralCrossRef Ainslie M, Miller CA, Brown B, Davidson N, Fox DJ, Schmitt M: Multiparametric CMR assessment of RV apical versus septal Pacing Study (MAPS) - preliminary acute hemodynamic findings. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O85-10.1186/1532-429X-15-S1-P85.PubMedCentralCrossRef
60.
go back to reference Muzzarelli S, Monney P, O’Brien K, Faletra F, Moccetti T, Vogt P, Schwitter J: Quantification of aortic valve regurgitation by phase-contrast magnetic resonance in patients with bicuspid aortic valve: where to measure the flow?. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O37-10.1186/1532-429X-15-S1-O37.PubMedCentralCrossRef Muzzarelli S, Monney P, O’Brien K, Faletra F, Moccetti T, Vogt P, Schwitter J: Quantification of aortic valve regurgitation by phase-contrast magnetic resonance in patients with bicuspid aortic valve: where to measure the flow?. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O37-10.1186/1532-429X-15-S1-O37.PubMedCentralCrossRef
61.
go back to reference Hart C, Gabbert DD, Voges I, Jerosch-Herold M, Andrade A, Pham M, Hansen T, Kramer H-H, Rickers C: New insights in the Fontan circulation: 4-dimensional respiratory- and ECG-triggered phase contrast magnetic resonance imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O38-PubMedCentral Hart C, Gabbert DD, Voges I, Jerosch-Herold M, Andrade A, Pham M, Hansen T, Kramer H-H, Rickers C: New insights in the Fontan circulation: 4-dimensional respiratory- and ECG-triggered phase contrast magnetic resonance imaging. J Cardiovasc Magn Reson. 2013, 15 (suppl 1): O38-PubMedCentral
62.
go back to reference Markl M, Kilner PJ, Ebbers T: Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011, 13: 7-10.1186/1532-429X-13-7.PubMedCentralCrossRefPubMed Markl M, Kilner PJ, Ebbers T: Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011, 13: 7-10.1186/1532-429X-13-7.PubMedCentralCrossRefPubMed
Metadata
Title
Highlights of the 16th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance
Authors
John-Paul Carpenter
Amit R Patel
Juliano Lara Fernandes
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2013
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-15-60

Other articles of this Issue 1/2013

Journal of Cardiovascular Magnetic Resonance 1/2013 Go to the issue